Media coverage about Healthequity (NASDAQ:HQY) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Healthequity earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.1263186115454 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s analysis:
Several research firms recently weighed in on HQY. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. Zacks Investment Research downgraded Healthequity from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Robert W. Baird restated a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Oppenheimer restated a “buy” rating and set a $61.00 price objective on shares of Healthequity in a research note on Wednesday, September 6th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $56.00 price objective on shares of Healthequity in a research note on Tuesday, September 5th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $57.50.
Shares of Healthequity (HQY) opened at $51.46 on Friday. The firm has a market capitalization of $3,137.55, a price-to-earnings ratio of 82.33, a price-to-earnings-growth ratio of 2.27 and a beta of 1.75. Healthequity has a 12 month low of $37.62 and a 12 month high of $55.31.
Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.13. Healthequity had a return on equity of 13.93% and a net margin of 20.27%. The firm had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. During the same quarter in the previous year, the business earned $0.16 EPS. The firm’s revenue for the quarter was up 28.7% on a year-over-year basis. sell-side analysts predict that Healthequity will post 0.7 earnings per share for the current year.
In other news, major shareholder Berkley Capital, Llc sold 700 shares of Healthequity stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $52.05, for a total transaction of $36,435.00. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Frank Medici sold 419,504 shares of Healthequity stock in a transaction on Monday, November 6th. The shares were sold at an average price of $52.97, for a total value of $22,221,126.88. Following the transaction, the director now owns 6,381 shares in the company, valued at approximately $338,001.57. The disclosure for this sale can be found here. Insiders sold a total of 1,743,212 shares of company stock worth $91,090,651 in the last three months. Company insiders own 29.00% of the company’s stock.
WARNING: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/12/02/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-healthequity-hqy-stock-price.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.